Phase 3 Data Show That TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine Significantly Improves Event-Free Survival and Overall Survival in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia

PR Newswire
December 12, 2021 — 09:00 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: America Casino China chinese europe healthcare Hong Kong Macau medicine singapore stock market Suzhou taiwan University

Related News:

LG STRENGTHENS EUROPEAN PRESENCE WITH ITS KITCHEN SOLUTIONS SHOWCASE AT MDW 2024

April 18, 2024 — 09:00

National University of Singapore’s IES, The Rockefeller Foundation Advance Renewable Energy Connectivity in Southeast Asia

April 18, 2024 — 09:00

JA Solar Partners with INPOS to Donate Mobile PV System to Vietnam Electric Power University

April 17, 2024 — 18:37

BitoGroup’s Strategic Expansion Doubles Market Reach in Taiwan

April 17, 2024 — 18:30

Students from JA Greece Win 2024 De La Vega Global Entrepreneurship Award

April 17, 2024 — 03:00

Orion X7 Unleashed: A Celebration of Innovation at the Sunseeker Lawn Banquet

April 17, 2024 — 02:34

Bridgewise secures $21 million in new funding to support the global expansion of its AI-powered financial intelligence platform for global securities

April 16, 2024 — 12:01

International Film Camp Awards Winners

April 15, 2024 — 14:19

Flash News: OKX Wallet Integrates with Firefly, Enhancing Web3 Social Experience

April 14, 2024 — 13:11